Home › COPD › Texas › McKinney
COPD clinical trials in McKinney, TX
5 studies for COPD are looking for participants at sites in and around McKinney (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, McKinney
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
RecruitingPhase 2
- Metroplex Pulmonary and Sleep Center, McKinney
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
RecruitingPhase 2
- WB Contracted Clinical Research Site, McKinney
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
- Research Site, McKinney
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RecruitingPhase 3
- Research Site, McKinney
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA23 studies
- Miami, FL18 studies
- Birmingham, AL17 studies
- Boston, MA17 studies
- Orlando, FL15 studies
- Houston, TX15 studies
- Baltimore, MD14 studies
- Chicago, IL14 studies
- Dallas, TX12 studies
- Pittsburgh, PA12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in McKinney
- Heart Failure7 studies
- Type 2 Diabetes6 studies
- Asthma5 studies
- Chronic Kidney Disease4 studies
- Cardiovascular Disease4 studies
- Obesity4 studies
- Atherosclerosis3 studies
- Interstitial Lung Diseases3 studies
- Graves Disease3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.